835 articles
Colin Lake, Vice President of Digital Business Transformation for Neurology at UCB, discusses the company’s approach to digital solutions and how they...
David Henley, MD, Executive Medical Director, Alzheimer’s Disease Global Medical Affairs, Neurology Business Group at Eisai Inc.
Jean Ford a 78-year-old diabetic and cancer survivor discusses the challenges she faced from her type-II diabetes as well as the treatment plan and educ...
Michael Aragon, Chief Medical Officer of Outset Medical based in San Jose, California, discusses how the company is reducing the cost and complexity o...
Jean-Francois Boileau, MD, MSc, FRCSC, surgical oncologist at Jewish General Hospital Segal Cancer Centre; associate professor of surgery and oncology...
Maria Maccecchini, PhD, CEO of Annovis Bio discusses the company's lead program ANVS401 that has shown that it lowers levels of neurotoxic proteins f...
Rob Etherington, CEO at Clene Nanomedicine discusses the company's lead drug candidate CNM-Au8, a catalytically active gold nanotherapeutic that drives ...
Vivek Subbiah, MD, Associate Professor in the Investigational Cancer Therapeutics department and Center Clinical Medical Director of the Clinical Center...
Ben Chew discuss two abstracts made available virtually by the World Congress of Endourology (WCET) titled " Identifying Predictors of Sepsis Post-Urete...
Jeffrey Stark, MD, Head of US Medical Immunology at UCB discusses new data from a network meta-analysis (NMA) demonstrating that bimekizumab was associa...